We are live on ! Find out more
NVTA

Invitae Corporation

Delisted

NVTA was delisted on the 5th of February, 2024.

183 hedge funds and large institutions have $1.66B invested in Invitae Corporation in 2019 Q1 according to their latest regulatory filings, with 64 funds opening new positions, 66 increasing their positions, 37 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

191% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 22

162% more capital invested

Capital invested by funds: $633M → $1.66B (+$1.03B)

78% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 37

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

37% more call options, than puts

Call options by funds: $11.8M | Put options by funds: $8.58M

29% more funds holding

Funds holding: 142183 (+41)

Holders
183
Holders Change
+41
Holders Change %
+28.87%
% of All Funds
3.96%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.06%
New
64
Increased
66
Reduced
37
Closed
22
Calls
$11.8M
Puts
$8.58M
Net Calls
+$3.2M
Net Calls Change
+$1.22M
Name Holding Trade Value Shares
Change
Change in
Stake
GWMIA
176
Global Wealth Management Investment Advisory
Florida
$8K +$6.17K +350 New
GWM
177
Geneos Wealth Management
Colorado
$5K
PCP
178
Proficio Capital Partners
Massachusetts
$5K +$4K +227 New
BEI
179
Benjamin Edwards Inc
Missouri
$5K +$4.02K +228 New
CFGS
180
Concourse Financial Group Securities
Alabama
$4K +$3.76K +213 New
BWA
181
BDO Wealth Advisors
Florida
$1K -$1.76K -100 -67%
AssetMark Inc
182
AssetMark Inc
California
$1K +$441 +25 New
Millennium Management
183
Millennium Management
New York
-$7.48M -676,015 Closed
Public Sector Pension Investment Board (PSP Investments)
184
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
-$2.76M -249,300 Closed
OAM
185
Oxford Asset Management
United Kingdom
-$1.89M -170,800 Closed
SSA
186
Schonfeld Strategic Advisors
New York
-$1.07M -96,883 Closed
Marshall Wace
187
Marshall Wace
United Kingdom
-$1.01M -90,953 Closed
Balyasny Asset Management
188
Balyasny Asset Management
Illinois
-$849K -76,742 Closed
Susquehanna International Group
189
Susquehanna International Group
Pennsylvania
-$1.1M -62,147 Closed
MWNA
190
Marshall Wace North America
New York
-$378K -34,089 Closed
HF
191
HRT Financial
New York
-$282K -25,506 Closed
SCA
192
Secor Capital Advisors
New York
-$257K -23,219 Closed
WCM
193
Weld Capital Management
New York
-$240K -21,661 Closed
TEE
194
Tibra Equities Europe
United Kingdom
-$212K -19,200 Closed
GF
195
Gabelli Funds
New York
-$199K -18,000 Closed
EMG
196
Ellington Management Group
Connecticut
-$166K -15,000 Closed
TI
197
Trexquant Investment
Connecticut
-$158K -14,297 Closed
ECM
198
Element Capital Management
New York
-$154K -13,915 Closed
Capital Fund Management (CFM)
199
Capital Fund Management (CFM)
France
-$128K -11,600 Closed
VAM
200
Verity Asset Management
North Carolina
-$126K -11,410 Closed

NVTA Hedge Fund Activity: Q1 2019 in Review

183 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Invitae Corporation (NVTA) for Q1 2019, worth a combined $1.66B — up 162% from $633M a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new NVTA positions and 22 closed out — a net gain of 42 holders — while 66 added to existing stakes and 37 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $32.5M. The largest seller was OrbiMed, cutting an estimated $10.6M.

  • 183 institutional investors held Invitae Corporation (NVTA) as of Q1 2019, up from 142 in Q4 2018.
  • Funds reported $1.66B of Invitae Corporation stock for Q1 2019, up 162% quarter-over-quarter.
  • 64 funds opened new Invitae Corporation positions in Q1 2019 and 22 closed out, a net change of +42 holders.
  • The largest Invitae Corporation buyer in Q1 2019 was AllianceBernstein, an estimated $32.5M added.
  • The largest Invitae Corporation seller in Q1 2019 was OrbiMed, an estimated $10.6M sold.

Based on aggregated 13F filings for Q1 2019.